Gateway Biotechnology

Science-based Solutions to Hearing Disorders

Over 1.5 billion people worldwide suffer from hearing disorders, including hearing loss due to age-related hearing impairment, noise exposure (i.e., Noise-Induced Hearing Loss [NIHL]), Meniere’s disease, or tinnitus.

Gateway Biotechnology Science-based Solutions to Hearing Disorders

Over 1.5 billion people worldwide suffer from hearing disorders, including hearing loss due to aging (i.e., Age-Related Hearing Loss [ARHL]), noise exposure (i.e., Noise-Induced Hearing Loss [NIHL]), or tinnitus.

In the U.S. alone, hearing disorders affect 73 million

The National Institute for Occupational Safety and Health estimates that each year over 22 million workers are exposed to damaging levels of noise and hearing loss is the most common work-related illness in the U.S. Currently.
Customer focused
Value oriented
Quality obsessed
People centric
What we do

Over 1.5 billion people worldwide suffer from hearing disorders

Drug Development

An estimated 20 million people in the US suffer from bothersome tinnitus and over 30 million in the US suffer from noise-induced hearing loss.

Drug Development

Our product pipeline includes multiple drugs to treat tinnitus and treat or prevent noise-induced hearing loss.
Read More

Telehealth

Tinnitus Activities Treatment (TAT) is an effective therapy for tinnitus treatment that takes a holistic approach to tinnitus management.

Telehealth

We are conducting a clinical study to assess the effectiveness of an online TAT therapy.
Read More

Gene Therapy

Clinical applications of gene therapy have advanced rapidly in recent years.

Gene Therapy

We are currently conducting pre-clinical studies to test the effectiveness of an AAV therapy to treating hearing disorders.
Read More
experience excellence

Robust pipeline for science-based solutions to disorders

We have developed animal model systems for pre-clinical trials of drug candidates and have advanced our leading drug candidate to a clinical Phase II trial with the US Army. NIH-supported research is now enabling us to move additional candidates through our discovery pipeline.
Testimonials
Curious about what people say about us & our services?
Our Mission

With a decade of product development funded by initial investment

From co-founders and subsequent awards from National Institutes of Health (NIH), Gateway Biotechnology has been developing drug candidates with proven safety records to combat hearing disorders. Our innovative approach, grounded in a deep understanding.
Passion is what drives us

We are actively seeking partnerships and investment opportunities. Send us a message if you are interested

Let's discuss now
Get in touch with us
We respond within 48 hours

We answer all email and requests as they come in. If you have an urgent matter or would like to place an order please click the link below to give us a call.

+314-620-5737

jbao@gatewaybiotechnology.com

1154 North Warson Rd.
St. Louis, MO 63132